Purdue opioid deal may be worth less than drugmaker promised

QUESTIONS ARE GROWING about the value of the proposed settlement between Purdue Pharma and a number of states and cities suing for damages caused by the opioid crisis. / BLOOMBERG NEWS FILE PHOTO/JOHN MOORE/GETTY IMAGES
QUESTIONS ARE GROWING about the value of the proposed settlement between Purdue Pharma and a number of states and cities suing for damages caused by the opioid crisis. / BLOOMBERG NEWS FILE PHOTO/JOHN MOORE/GETTY IMAGES
WILMINGTON, Del. – Purdue Pharma LP’s deal to escape thousands of lawsuits over its role in the U.S. opioid crisis may be provide less than half the $10 billion that the drugmaker has promised, said three people familiar with details of the proposal. The settlement Purdue filed in bankruptcy court Sunday includes just $4.4 billion in…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -